+10000000)+'&millis='+new Date().getTime()+'&zid=472&keywords=biovail&referrer='+encodeURIComponent(document.location)+')
Canadian drug maker Biovail Corp., which was formerly headed by prominent Thoroughbred owner-breeder Eugene Melnyk, agreed March 24 to pay a $10-million fine to resolve federal regulators' charges of civil accounting fraud and deceiving investors and analysts.
Tuesday, March 25, 2008The U.S. Securities and Exchange Commission has opened an informal inquiry into the accounting and financial-reporting practices of Eugene Melnyk's pharmaceutical company Biovail Corp.
Friday, November 21, 2003+10000000)+'&millis='+new Date().getTime()+'&zid=473&keywords=biovail&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=476&keywords=biovail&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=441&keywords=biovail&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=366&keywords=biovail&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=466&referrer='+encodeURIComponent(document.location)+')
Copyright © 2013 Blood-Horse Publications. All rights reserved internationally.
+10000000)+'&millis='+new Date().getTime()+'&zid=601&referrer='+encodeURIComponent(document.location)+')